Prime Medicine and The Real Brokerage Report Mixed Q2 Earnings

Prime Medicine reported better-than-expected GAAP EPS and revenue for Q2, while The Real Brokerage missed GAAP EPS estimates despite exceeding revenue projections. These mixed results highlight varying financial performances within the market.